Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Stefan Ebmeyer, MD 00493302883
stefan.ebmeyer@thermofisher.com


Faranak Fassihianifard 00493302883
faranak.fassihianifard@thermofisher.com


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Risk Stratification Using Midregional Proadrenomedullin in the ED
Back

Risk Stratification Using Midregional Proadrenomedullin in the ED

Recruiting

Open to: ALL

Age: 18.0 - N/A

Basingstoke Southampton

Medical Conditions

Infections

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as outpatients is essential for improving the workflow within the ED.

The rationale of this IDEAL+ study is to safely decrease the number of hospital admissions through identification of low risk patients with the biomarker MR-proADM. This will has already been tested in the IDEAL - pilot study and results should be confirmed with this IDEAL+ study.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Oct 2021 Dec 2023

INTERVENTIONAL

Intervention Type : DEVICE
Intervention Description : MR-proADM ≤ 0.87 nmol/L together with routine clinical evaluation identifies patients with low disease severity who do not need to be hospitalized

Intervention Arm Group : MR-proADM guided arm;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Hampshire Hospitals NHS Foundation Trust
    Basingstoke
    RG24 9NA
  • University Hospital Southampton NHS Foundation Trust
    Southampton
    SO16 6YD

Faranak Fassihianifard 00493302883
faranak.fassihianifard@thermofisher.com


Stefan Ebmeyer, MD 00493302883
stefan.ebmeyer@thermofisher.com



The study is sponsored by Brahms AG



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT05108883
Last updated 20 April 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top